Antler-dcb@evsabpcs bone graft material and preparation method
By preparing antler-DCB@EVsABPCs bone graft material, the problems of immune rejection and insufficient bioactivity of existing biomedical materials in bone grafting have been solved, achieving bone regeneration effects with high safety and high repair rate, and promoting the coordinated growth of bone, blood vessels and nerve structures.
Patent Information
- Application Number
- CN202411682134.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-22
- Publication Date
- 2026-01-23
- Estimated Expiration
- 2044-11-22
AI Technical Summary
Existing biomedical materials suffer from immune rejection and insufficient bioactivity in bone transplantation, resulting in low clinical integration rates in engineered bone transplantation and failing to meet the requirements of high safety, high repair rate, and high bioactivity.
Deer antler-DCB@EVsABPCs bone graft material was prepared by decellularizing decellularized antler cancellous bone and combining it with ABPCs-EVs and HAMA hydrogel to form antler-DCB@ABPCs-EVs bone graft material. The bioactive molecules of ABPCs-EVs and the stability of HAMA hydrogel were utilized to achieve coordinated growth of bone, blood vessels and nerve structures.
Deer antler-DCB@EVsABPCs bone graft material exhibits strong osteogenic, angiogenic, neurogenic, and immunomodulatory capabilities, promoting bone regeneration, providing potential therapeutic interventions, and improving the effectiveness of bone repair.